Enavogliflozin/metformin hydrochloride - Daewoong Pharmaceutical
Alternative Names: DWJ-1525; Enavogliflozin/metformin hydrochloride; Envlomet SRLatest Information Update: 28 Jul 2023
Price :
$50 *
At a glance
- Originator Daewoong Pharmaceutical
- Class Antihypercalcaemics; Benzofurans; Biguanides; Cyclopropanes; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors; Sodium-glucose transporter 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Type 2 diabetes mellitus
Most Recent Events
- 13 Jun 2023 Registered for Type 2 diabetes mellitus in South Korea (PO)
- 24 May 2022 Daewoong Pharmaceutical completes a phase I trial in Type 2 diabetes mellitus (In volunteers) in South Korea (PO, Tablet) (NCT05192395)
- 15 Apr 2022 Phase-I clinical trials in Type 2 diabetes mellitus (In volunteers) in South Korea (PO, Tablet) (NCT05192395)